Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

IL-17 inhibitors for psoriasis may cause unexpected hair loss.

Ustekinumab treatment may reveal a genetic tendency for steatocystoma multiplex in psoriasis patients.

Increased Treg cells and IL-10 may help quick recovery in acute diffuse and total alopecia.

Targeting IL-17 could help treat pattern hair loss.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

People with severe hair loss have higher levels of a protein called interleukin 17 in their blood.

Atopy and altered T cell functions contribute to Alopecia Areata.

Clascoterone may be an effective topical treatment for hair loss.

Osmanthus fragrans var. aurantiacus Makino may help treat inflammation due to its antioxidative and anti-inflammatory properties.

Higher Interleukin 17A levels may indicate more severe alopecia areata.

Type 1/17 inflammation in psoriasis increases skin cell growth due to a molecule that could be a new treatment target.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

Ustekinumab treatment didn't prevent frontal fibrosing alopecia.

Future acne treatments should aggressively target inflammation to prevent scarring.

Certain immune system proteins are important for skin healing but can cause problems if there are too many of them.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

PCOS causes inflammation regardless of body weight.

PCOS is linked to inflammation, and certain markers could help in its treatment.

Mechanical stress may cause lesions in Hidradenitis suppurativa.

N-WASP is essential for healthy skin and preventing inflammation.

Nanoplastics can penetrate skin cells, triggering inflammation and immune responses.

Fibroblast and endothelial cell interactions are crucial in forming hypertrophic scars.

New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.

Muse cells from human bone marrow help reduce symptoms of atopic dermatitis in mice.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Gamma delta T cells in the skin help with healing and defense but can also cause autoimmune issues, and more research is needed to understand how they are activated.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.